RxDoctor Payments Data

Denice Hodgson Zingman, MD

Clinical Cardiac Electrophysiology · Iowa City, IANPI 1497729271

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $13,353 and has fallen 86.6% since, to $1,785 in 2025.

$16,887in general payments, 2019–2025

Across 88 payments — averaging $191.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$10K
  • Boston Scientific$4K
  • Abbott$1K
  • Impulse Dynamics (USA) Inc.$384
  • Biosense Webster, Inc.$298
  • ZOLL Respicardia, Inc.$205
  • plus $375 from 4 others
$117,330in research payments, 2019–2025

Across 44 payments — averaging $2666.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$91K
  • Impulse Dynamics (USA) Inc.$26K

What the payments were for

  • Consulting fees$8,25049%
  • Speaking & faculty fees$2,50015%
  • Travel & lodging$2,89117%
  • Food & beverage$3,24619%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,887 in reported general payments places this provider in the 55th percentile of 42 clinical cardiac electrophysiology providers in Iowa.

See all clinical cardiac electrophysiology providers in Iowa

Medicare billing

Part B allowed, 2024
$165,401
Medicare patients
1,664
Services billed
2,800

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban177$177,047
XareltoRivaroxaban21$22,767
MultaqDronedarone Hcl14$17,790
Dofetilide34$5,151
PradaxaDabigatran Etexilate Mesylate12$3,543
Flecainide Acetate76$3,065
Dabigatran EtexilateDabigatran Etexilate Mesylate13$2,905
Amiodarone Hcl84$1,691
Metoprolol Succinate89$1,111
Digoxin23$453
SotalolSotalol Hcl28$412
Diltiazem 24hr Er (Cd)Diltiazem Hcl18$320
Metoprolol Tartrate40$129

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →